Menu

scPharmaceuticals Inc. SCPH

Full chart Compare
Set alert

Price alert · SCPH

All alert types
5.67 0.00 (+0.00%)

At closeOct 7, 2025, 4:00 PM EDT

5.67 Day range 5.67

52-week range unavailable

YTD
+60.17%
1 year
+32.48%

Discussion (71)

Sign in to join the discussion

Goinglong SCPH 2 years ago #61

As painful as a week it was, it was just a short attack, in advance of what will very likely be a killer earnings call in Nov…..

As stated in other posts and as you all know, the company is facing a sales inflection, and people shorting the stock I would only guess will need to cover in a big way before Nov so they need to flush the SP down with the hopes of picking up the cheap shares

Also, by crushing the SP it makes the options cheaper to pick up, and now $5 calls are available to buy and make money on.

$5 is a gimme for mid Nov calls

Small caps like this are heavily manipulated. Tough to stomach as a long, but need to understand the game we are all playing.

Goinglong SCPH 2 years ago #62

Very interesting

Short interest on 9/13 was 4.2 M, this is at least a 2 year low, down from 5 M on the 8/30 read( Nasda website)

In the past 2 years the second lowest was 4.6 m, highest was 6.8M

That’s a HUGE swing….

I’m willing to bet current depression is driven by shorts swinging right back….covered 800k share early Sept only to pounce here in the last week.

Hopefully we bottomed out and will start to recover soon, Nov earnings call should deliver strong quarter over quarter growth with this fill rate going from 40 to 60 percent and stage 4 indication sales as a tail wind.

Goinglong SCPH 2 years ago #63

And they kinda gave guidance of over 24 m a quarter late next year , said they would be profitable around Q3-4 2025…..so looking at well over $100 annual sales for 2026

So we are basically 2.2x 2026 sales

No?

Goinglong SCPH 2 years ago #64

WTF- Biotech ETFs up, Russell up, why is SCPH getting crushed. If you take our last quarter of sales of 8 million X 4 = 32 million annually and divide by current market cap now at 217 m that’s 6.78x

So not even trading at a 7x of last quarter run rate, and sales definitely growing.

Are we oversold yet?

Goinglong SCPH 2 years ago #65

Ok, shorts crushed us, but hopefully time to buy back on the dip and play the swing. Charting the SP feels like we have about hit bottom, this should double after Nov call .Increased coverage rate and additional indication on top of the sales momentum they have.

Goinglong SCPH 2 years ago #66

I’m betting big on the fact that SCPH is going to have several extremely strong quarters coming up. I can’t help to feel also that the shorts are going to be doing a heavy exit before the November earnings call. There’s multiple catalysts that are just occurred that will no doubt drive very strong quarter over quarter growth.

Rarely have I seen a legitimate set up this great

Goinglong SCPH 2 years ago #67

Sleeper stock, sales will more than double by this time next year.

Fully funded, stronger pull through , new indication, expanding sales force all tail winds.

An additional indication early next year with even more feet on the street will be icing on the cake.

Goinglong SCPH 2 years ago #68

Wow, very impressed with SCPharma

Everything seems to be going right, I love the conservative approach to expansion and the path to profitability, even before the auto injector hits the market.

This company has a very bright feature, great investment opportunity in my opinion.

Goinglong SCPH 2 years ago #69

$8 m ( last quarter sales) x 4 = 32 m ( assuming no growth?)

32m x 7 ( multiple) = $224 m

Current market cap $250M

Now listen to the earning call and consider the multiple levers of growth that are in play

We are undervalued when you factor in the very real growth that is building

Strong buy!

Goinglong SCPH 2 years ago #70

Shorts are kinda screwed here, I just bought 30k shares in the last few days and it was really hard to do without driving the price up with each 1k. At many times shares just were not being offered up to buy.

This investor meeting IMO likely will drive a lot of interest to buy with the sales inflection they are in the middle of, Nov. quarterly call will be very interesting with the many tailwinds they have going for them.